J36 J35.0 J35.1
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patient groups: 1. male or female patients, age at least 18 years 2. written informed consent Only patient group A: patients with peritonsillar abscess and emergent tonsillectomy Only patient group B: patients with chronic tonsillitis (with 3 or more episodes of recidival acute tonsillitides per year) and scheduled for routine tonsillectomy Only patient group C: patients without acute or chronic tonsillitis, but scheduled for routine tonsilectomy due to rhonchopathy or obstructive sleep apnea syndrome
Exclusion criteria
Exclusion criteria: 1. therapy with steroids or other immunosuppressive therapy 2. severe chronic diseases in medical history 3. Therapy with coagulation inhibitors or abnormally low coagulation status
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in the T cell response of patients with peritonsillar abscess, chronic tonsillitis and tonsil hyperplasia regarding activation, proliferation and apoptosis and thereby investigate the existence of T cell specific parameters to systemic and local inflammation | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigation of the use of the tonsils, as an easily available secondary lymphoid organ, for the determination of the immune status of patients with severe local inflammatory reaction to sepsis | — |
Countries
Germany
Contacts
Integriertes Forschungs- und BehandlungszentrumSepsis und SepsisfolgenKlinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde